Updated rationale for the initial antipsychotic selection for patients with schizophrenia
Schizophrenia (Heidelb)
.
2024 Sep 2;10(1):74.
doi: 10.1038/s41537-024-00492-y.
Authors
Matej Markota
1
,
Robert J Morgan 3rd
2
,
Jonathan G Leung
2
3
Affiliations
1
Department of Psychiatry & Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA. Markota.Matej@mayo.edu.
2
Department of Psychiatry & Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
3
Department of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
PMID:
39223138
PMCID:
PMC11369117
DOI:
10.1038/s41537-024-00492-y
No abstract available
Publication types
Review